<dd id="rw0xn"></dd>
If you would like to learn more about the IAEA’s work, sign up for our weekly updates containing our most important news, multimedia and more.
IAEA-TECDOC-1310
English IAEA-TECDOC-1310 | 92-0-116802-0
158 pages | € 15.00 | Date published: 2002This publication describes the general scope of a Co-ordinated Research Project focused on the optimization of syntheses, quality control, in vitro and in vivo evaluation of F-18 and I-123 radiopharmaceuticals based on peptides with known or anticipated clinical potential. Selective labelling procedures using prosthetic groups were applied to both fluorine and iodine. Studies included investigation on the fate of the label, stability in vivo, biodistribution and pharmacokinetic studies in rodents and in cell culture. With respect to I-123, the work aimed at development of a simplified labelling kit using solid state systems.
More Information on reusing IAEA copyright material.
Orders and requests for information may also be addressed to:
Publishing Section
International Atomic Energy Agency
Vienna International Centre
PO Box 100, A-1400 Vienna,
Austria
Tel.: +43 1 2600 22529, +43 1 2600 22530
Email: sales.publications@iaea.org
<dd id="rw0xn"></dd>
